Astera Labs, Inc.
ALAB
$212.10
-$8.71-3.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 149.74% | 144.33% | 179.32% | 206.23% | 619.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.74% | 144.33% | 179.32% | 206.23% | 619.03% |
| Cost of Revenue | 172.78% | 171.62% | 218.98% | 185.72% | 655.71% |
| Gross Profit | 143.20% | 136.36% | 167.64% | 212.67% | 609.25% |
| SG&A Expenses | -11.44% | -45.49% | 361.60% | 387.67% | 438.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.35% | -0.05% | 239.69% | 213.54% | 257.57% |
| Operating Income | 263.36% | 113.60% | -98.40% | -349.97% | -38.23% |
| Income Before Tax | 459.72% | 127.01% | 0.07% | 896.84% | 12.30% |
| Income Tax Expenses | 91.43% | -180.29% | -285.87% | 234.69% | -265.66% |
| Earnings from Continuing Operations | 778.76% | 134.22% | 72.52% | -143.05% | 62.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 778.76% | 134.22% | 72.52% | -143.05% | 62.28% |
| EBIT | 263.36% | 113.60% | -98.40% | -349.97% | -38.23% |
| EBITDA | 274.21% | 115.07% | -88.31% | -436.82% | -37.33% |
| EPS Basic | 737.04% | 111.02% | -58.30% | 41.97% | 91.12% |
| Normalized Basic EPS | 437.57% | 108.70% | -75.84% | 290.48% | 79.34% |
| EPS Diluted | 680.00% | 110.17% | -62.45% | 41.97% | 90.86% |
| Normalized Diluted EPS | 413.58% | 107.96% | -78.21% | 290.48% | 79.34% |
| Average Basic Shares Outstanding | 6.59% | 210.66% | 313.77% | 318.55% | 324.42% |
| Average Diluted Shares Outstanding | 14.76% | 239.06% | 359.49% | 318.55% | 324.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |